Addition of lomustine for bevacizumab-refractory recurrent glioblastoma

Michaela Tonder, Günter Eisele, Tobias Weiss, Silvia Hofer, Katharina Seystahl, Antonios Valavanis, Roger Stupp, Michael Weller, Patrick Roth*

*Corresponding author for this work

Research output: Contribution to journalLetter

5 Scopus citations
Original languageEnglish (US)
Pages (from-to)1436-1440
Number of pages5
JournalActa Oncologica
Volume53
Issue number10
DOIs
StatePublished - Oct 1 2014

ASJC Scopus subject areas

  • Hematology
  • Oncology
  • Radiology Nuclear Medicine and imaging

Cite this

Tonder, M., Eisele, G., Weiss, T., Hofer, S., Seystahl, K., Valavanis, A., Stupp, R., Weller, M., & Roth, P. (2014). Addition of lomustine for bevacizumab-refractory recurrent glioblastoma. Acta Oncologica, 53(10), 1436-1440. https://doi.org/10.3109/0284186X.2014.920960